Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription


1 Am Heart J
3 Am J Cardiol
1 Am J Med
1 Ann Thorac Surg
2 Arterioscler Thromb Vasc Biol
1 Chest
6 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
1 Circ J
1 Circ Res
4 Circulation
1 Clin Cardiol
1 Clin Chem
2 Heart
1 Hypertension
7 J Am Coll Cardiol
1 J Clin Endocrinol Metab
1 J Electrocardiol
2 J Thorac Cardiovasc Surg
5 Lancet Diabetes Endocrinol
10 PLoS One

    Am Heart J

  1. WEI J, Mehta PK, Grey E, Garberich RF, et al
    Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol.
    Am Heart J. 2017;191:30-36.
    >> Share

    Am J Cardiol

  2. LAMELAS P, Schwalm JD, Quazi I, Mehta S, et al
    Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes.
    Am J Cardiol. 2017 Jul 29. pii: S0002-9149(17)31216.
    >> Share

  3. ALENEZI F, Brummett BH, Boyle SH, Samad Z, et al
    Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial).
    Am J Cardiol. 2017 Jul 29. pii: S0002-9149(17)31212.
    >> Share

  4. KURTUL A, Ozturk S
    WITHDRAWN: Relation of Mean Platelet Volume-to-Lymphocyte Ratio and Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2017 Aug 8. pii: S0002-9149(17)31290.
    >> Share

    Am J Med

  5. SAFIRI S, Ayubi E
    Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular Disease: Methodological Issues.
    Am J Med. 2017;130:e459.
    >> Share

    Ann Thorac Surg

  6. FORTIN J, Vaillancourt R, Vigneault L, Laflamme M, et al
    Unusual Cause of Life-Threatening Hemoptysis During Cardiac Operation: Surgical Management Revisited.
    Ann Thorac Surg. 2017;104:e251-e252.
    >> Share

    Arterioscler Thromb Vasc Biol

  7. RAFFIELD LM, Zakai NA, Duan Q, Laurie C, et al
    D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.
    Arterioscler Thromb Vasc Biol. 2017 Sep 14. pii: ATVBAHA.117.310073.
    >> Share

  8. CHEN X, Zhang Y, Chen Q, Li Q, et al
    Lower Plasma Fetuin-A Levels Are Associated With a Higher Mortality Risk in Patients With Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2017 Sep 14. pii: ATVBAHA.117.309700.
    >> Share


  9. HALLE TR, Oh MS, Collop NA, Quyyumi AA, et al
    Surgical Treatment of Obstructive Sleep Apnea on Cardiovascular Outcomes: A Systematic Review.
    Chest. 2017 Sep 15. pii: S0012-3692(17)32696-X. doi: 10.1016/j.chest.2017.
    >> Share

    Circ Cardiovasc Interv

  10. PELLICANO M, Lavi I, De Bruyne B, Vaknin-Assa H, et al
    Validation Study of Image-Based Fractional Flow Reserve During Coronary Angiography.
    Circ Cardiovasc Interv. 2017;10.
    >> Share

  11. MORRIS PD, Gunn JP
    Computing Fractional Flow Reserve From Invasive Coronary Angiography: Getting Closer.
    Circ Cardiovasc Interv. 2017;10.
    >> Share

    Letter by Piciche Regarding Article, "Effect of Permanent Right Internal Mammary Artery Closure on Coronary Collateral Function and Myocardial Ischemia".
    Circ Cardiovasc Interv. 2017;10.
    >> Share

  13. Correction to: Time-Course Reduction in Patient Exposure to Radiation From Coronary Interventional Procedures: The Greater Paris Area Percutaneous Coronary Intervention Registry.
    Circ Cardiovasc Interv. 2017;10.
    >> Share

  14. KINNAIRD T, Anderson R, Ossei-Gerning N, Cockburn J, et al
    Coronary Perforation Complicating Percutaneous Coronary Intervention in Patients With a History of Coronary Artery Bypass Surgery: An Analysis of 309 Perforation Cases From the British Cardiovascular Intervention Society Database.
    Circ Cardiovasc Interv. 2017;10.
    >> Share

  15. SHAH B, Baber U, Pocock SJ, Krucoff MW, et al
    White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).
    Circ Cardiovasc Interv. 2017;10.
    >> Share

    Circ Cardiovasc Qual Outcomes

    Preprints and Cardiovascular Science: Prescient or Premature?
    Circ Cardiovasc Qual Outcomes. 2017;10.
    >> Share

    Circ J

  17. TANAKA T, Nishigaki K, Minatoguchi S, Nawa T, et al
    Mobilized Muse Cells After Acute Myocardial Infarction Predict Cardiac Function and Remodeling in the Chronic Phase.
    Circ J. 2017 Sep 20. doi: 10.1253/circj.CJ-17-0552.
    >> Share

    Circ Res

  18. SHARP TE, Schena GJ, Hoachlandr-Hobby AR, Starosta T, et al
    Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.
    Circ Res. 2017 Sep 14. pii: CIRCRESAHA.117.311174.
    >> Share


  19. REBOLL MR, Korf-Klingebiel M, Klede S, Polten F, et al
    Endoplasmic Reticulum Membrane Protein Complex Subunit 10 (EMC10) is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
    Circulation. 2017 Sep 20. pii: CIRCULATIONAHA.117.029980.
    >> Share

  20. CREA F, Libby P
    Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.
    Circulation. 2017;136:1155-1166.
    >> Share

    Preprints and Cardiovascular Science: Prescient or Premature?
    Circulation. 2017 Sep 14. pii: CIRCULATIONAHA.117.031238.
    >> Share

  22. WANG WE, Li L, Xia X, Fu W, et al
    Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.
    Circulation. 2017;136:834-848.
    >> Share

    Clin Cardiol

  23. HWANG IC, Choi SJ, Choi JE, Ko EB, et al
    Comparison of mid- to long-term clinical outcomes between anatomical testing and usual care in patients with suspected coronary artery disease: A meta-analysis of randomized trials.
    Clin Cardiol. 2017 Sep 15. doi: 10.1002/clc.22799.
    >> Share

    Clin Chem

  24. KOENIG W
    C-Reactive Protein and Cardiovascular Risk: Will the Controversy End after CANTOS?
    Clin Chem. 2017 Sep 20. pii: clinchem.2017.273243.
    >> Share


  25. ALBADRI A, Wei J, Mehta PK, Shah R, et al
    Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
    Heart. 2017 Sep 20. pii: heartjnl-2017-311921. doi: 10.1136/heartjnl-2017-311921
    >> Share

  26. ZHAO M, Vaartjes I, Graham I, Grobbee D, et al
    Sex differences in risk factor management of coronary heart disease across three regions.
    Heart. 2017 Sep 20. pii: heartjnl-2017-311429. doi: 10.1136/heartjnl-2017-311429
    >> Share


  27. TERENTES-PRINTZIOS D, Vlachopoulos C, Xaplanteris P, Ioakeimidis N, et al
    Cardiovascular Risk Factors Accelerate Progression of Vascular Aging in the General Population Results From the CRAVE Study (Cardiovascular Risk Factors Affecting Vascular Age).
    Hypertension. 2017 Sep 18. pii: HYPERTENSIONAHA.117.09633.
    >> Share

    J Am Coll Cardiol

  28. GURBEL PA, Navarese EP, Tantry US
    Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
    J Am Coll Cardiol. 2017;70:1463-1466.
    >> Share

  29. CALEYACHETTY R, Thomas GN, Toulis KA, Mohammed N, et al
    Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women.
    J Am Coll Cardiol. 2017;70:1429-1437.
    >> Share

  30. BEA JW, Sweitzer NK
    More Appropriate Cardiovascular Risk Screening Through Understanding Complex Phenotypes: Mind the Gap.
    J Am Coll Cardiol. 2017;70:1438-1440.
    >> Share

  31. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    >> Share

  32. DAMP JB, Mendes LA, Goldman M, Stern EH, et al
    ABIM/ACC Competency-Based Education Pilot in Internal Medicine and Cardiovascular Disease.
    J Am Coll Cardiol. 2017;70:1534-1535.
    >> Share

  33. BONACA MP, Storey RF, Theroux P, Steg PG, et al
    Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.
    J Am Coll Cardiol. 2017;70:1368-1375.
    >> Share

  34. GOTBERG M, Cook CM, Sen S, Nijjer S, et al
    The Evolving Future of Instantaneous Wave-Free Ratio and Fractional Flow Reserve.
    J Am Coll Cardiol. 2017;70:1379-1402.
    >> Share

    J Clin Endocrinol Metab

  35. KANG YM, Cho YK, Lee SE, Park JY, et al
    Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study.
    J Clin Endocrinol Metab. 2017;102:3443-3451.
    >> Share

    J Electrocardiol

  36. CIPRIANI A, D'Amico G, Brunello G, Perazzolo Marra M, et al
    The electrocardiographic "triangular QRS-ST-T waveform" pattern in patients with ST-segment elevation myocardial infarction: Incidence, pathophysiology and clinical implications.
    J Electrocardiol. 2017 Aug 16. pii: S0022-0736(17)30264.
    >> Share

    J Thorac Cardiovasc Surg

  37. HAWKINS RB, Mehaffey JH, Yount KW, Yarboro LT, et al
    Coronary artery bypass grafting bundled payment proposal will have significant financial impact on hospitals.
    J Thorac Cardiovasc Surg. 2017 Jul 29. pii: S0022-5223(17)31577.
    >> Share

  38. WANG L, Wang H, Hou X
    Short-term effects of preoperative beta-blocker use for isolated coronary artery bypass grafting: A systematic review and meta-analysis.
    J Thorac Cardiovasc Surg. 2017 Aug 24. pii: S0022-5223(17)31785.
    >> Share


  39. DEVEREAUX PJ, Biccard BM, Chan MTV
    High-Sensitivity Troponin Levels, Ischemia, and Mortality-Reply.
    JAMA. 2017;318:865.
    >> Share

    High-Sensitivity Troponin Levels, Ischemia, and Mortality.
    JAMA. 2017;318:864-865.
    >> Share

    Lancet Diabetes Endocrinol

  41. SABATINE MS, Leiter LA, Wiviott SD, Giugliano RP, et al
    Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.
    Lancet Diabetes Endocrinol. 2017 Sep 14. pii: S2213-8587(17)30313.
    >> Share

  42. HOLMAN RR, Coleman RL, Chan JCN, Chiasson JL, et al
    Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Lancet Diabetes Endocrinol. 2017 Sep 12. pii: S2213-8587(17)30309.
    >> Share

  43. VACCARO O, Masulli M, Nicolucci A, Bonora E, et al
    Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
    Lancet Diabetes Endocrinol. 2017 Sep 12. pii: S2213-8587(17)30317.
    >> Share

  44. FONSECA VA, Lovre D
    Pioglitazone versus sulfonylureas: cardiovascular outcomes with older diabetes drugs.
    Lancet Diabetes Endocrinol. 2017 Sep 13. pii: S2213-8587(17)30320.
    >> Share

  45. NAUCK MA, Meier JJ
    Break point instead of ACE: acarbose, post-load glycaemic excursions, and cardiovascular events.
    Lancet Diabetes Endocrinol. 2017 Sep 12. pii: S2213-8587(17)30318.
    >> Share

    PLoS One

  46. ALBADRI A, Lai K, Wei J, Landes S, et al
    Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    PLoS One. 2017;12:e0177684.
    >> Share

  47. TAN Q, Jiang X, Huang S, Zhang T, et al
    The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0177872.
    >> Share

  48. RYABOV VV, Kirgizova MA, Suslova TE, Karas SI, et al
    Relationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMI.
    PLoS One. 2017;12:e0176900.
    >> Share

  49. KOHARA M, Masuda T, Shiizaki K, Akimoto T, et al
    Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.
    PLoS One. 2017;12:e0178971.
    >> Share

  50. TSCHARRE M, Egger F, Machata M, Rohla M, et al
    Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
    PLoS One. 2017;12:e0179349.
    >> Share

  51. YE Y, Yang M, Zhang S, Zeng Y, et al
    Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A meta-analysis.
    PLoS One. 2017;12:e0179756.
    >> Share

  52. WILLIS TA, West R, Rushforth B, Stokes T, et al
    Variations in achievement of evidence-based, high-impact quality indicators in general practice: An observational study.
    PLoS One. 2017;12:e0177949.
    >> Share

  53. ALGHAMDI M, Al-Mallah M, Keteyian S, Brawner C, et al
    Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project.
    PLoS One. 2017;12:e0179805.
    >> Share

  54. JANGGEN C, Grani C, Brunner J, Trachsel LD, et al
    Sports engagement and age at first myocardial infarction in men under 55 years of age.
    PLoS One. 2017;12:e0184035.
    >> Share

  55. LEE SH, Yang JH, Choi SH, Park TK, et al
    Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion.
    PLoS One. 2017;12:e0176737.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016